Over 5 million Americans have atrial fibrillation, but many don’t know the red flags.

The FDA approved Abbott's Volt PFA System for atrial fibrillation, supported by VOLT-AF trial data showing strong safety and ...

Boston Scientific ($BSX) announced an update on their ongoing clinical study. Study OverviewThis global Boston Scientific trial, officially titled ...

Background Despite anticoagulation, patients with atrial fibrillation (AF) experience persistent elevated cardiovascular risk ...

Atrial fibrillation (AFib) is related to inflammation in your body, like other heart disease. Some research suggests that inflammation can cause AFib or make it worse if you already have it. Other ...

Lab-grown hearts with immune cells develop atrial fibrillation after chronic inflammation, offering a new way to test ...

Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.

Introduction Atrial fibrillation (AF) is the leading cause of cardioembolic stroke and is associated with increased stroke severity and fatality. Early identification of AF is essential for adequate ...

Abbott will soon enter the competitive U.S. pulsed field ablation (PFA) market, having just received FDA approval for its ...

The holidays are a festive time often filled with rich dishes and plenty of alcohol. But too much good cheer can lead to an increased risk of holiday heart syndrome.